Equity Details
Price & Market Data
Price: $3.98
Daily Change: +$0.02 / 0.50%
Daily Range: $3.90 - $4.10
Market Cap: $37,337,752
Daily Volume: 23,516
Performance Metrics
1 Week: 7.86%
1 Month: 30.92%
3 Months: 5.29%
6 Months: -1.00%
1 Year: -84.69%
YTD: -7.44%
About Tvardi Therapeutics, Inc. (TVRD)
Essential market details for Tvardi Therapeutics, Inc. (TVRD). Current price: 3.98, daily change: +$0.02 / 0.50%. Market cap: 37,337,752. Dive into YTD, 1-week, and 6-month performance.
Company Details
Employees: 12
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.